PIN1 and ovarian cancer: Nevertheless, we recently demonstrated the efficacy of virtual screening (VS) in identifying a novel promising noncovalent, reversible PIN1 inhibitor, compound VS10, which showed antiproliferative activity in four ovarian cancer cell lines and reduced the levels of PIN1 downstream targets, such as β‐catenin, cyclin D1, and pSer473‐Akt.24